These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2409417)

  • 1. Use of stable prostacyclin analogue ZK 36 374 to treat severe lower limb ischaemia.
    Chiesa R; Vicari A; Mari G; Galimberti M; Di Carlo V; Pozza G
    Lancet; 1985 Jul; 2(8446):95-6. PubMed ID: 2409417
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical benefits of iloprost, a stable prostacyclin (PGI2) analog, in severe peripheral arterial disease (PAD).
    Oberender H; Krais T; Schäfer M; Belcher G
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():311-6. PubMed ID: 2473610
    [No Abstract]   [Full Text] [Related]  

  • 3. Tolerance of Iloprost and results of treatment of chronic severe lower limb ischaemia in diabetic patients. A retrospective study of 64 consecutive cases.
    Duthois S; Cailleux N; Benosman B; Lévesque H
    Diabetes Metab; 2003 Feb; 29(1):36-43. PubMed ID: 12629446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early and late administration of a PGI2-analogue, ZK 36 374 (iloprost): effects on myocardial preservation, collateral blood flow and infarct size.
    Smith EF; Gallenkämper W; Beckmann R; Thomsen T; Mannesmann G; Schrör K
    Cardiovasc Res; 1984 Mar; 18(3):163-73. PubMed ID: 6200229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet responses observed during and after infusions of the prostacyclin analog ZK 36 374.
    Yardumian DA; Mackie IJ; Bull H; Machin SJ
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():359-62. PubMed ID: 2408446
    [No Abstract]   [Full Text] [Related]  

  • 6. Trial of iloprost versus aspirin treatment for critical limb ischaemia of thromboangiitis obliterans. The TAO Study.
    Fiessinger JN; Schäfer M
    Lancet; 1990 Mar; 335(8689):555-7. PubMed ID: 1689791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Our experience in using a synthetic prostacyclin analog in the treatment of critical ischemia of the extremities].
    Centorrino T; Versaci A; Ciccolo A; Terranova ML; Panté S; Barbera A; Cuzzocrea D
    G Chir; 1998 Oct; 19(10):399-403. PubMed ID: 9835185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential therapeutic mechanisms of stable prostacyclin (PGI2)-mimetics in severe peripheral vascular disease.
    Müller B; Krais T; Stürzebecher S; Witt W; Schillinger E; Baldus B
    Biomed Biochim Acta; 1988; 47(10-11):S40-4. PubMed ID: 2470358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved functional recovery of the isolated rat heart after 24 hours of hypothermic arrest with a stable prostacyclin analogue (ZK 36 374).
    van Gilst WH; Boonstra PW; Terpstra JA; Wildevuur CR; de Langen CD
    J Mol Cell Cardiol; 1983 Nov; 15(11):789-92. PubMed ID: 6197528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ischemia of the limbs. Angiodyn, Toulouse, October 1988].
    Vitoux JF
    Rev Prat; 1989 Mar; 39(7):587-8. PubMed ID: 2468177
    [No Abstract]   [Full Text] [Related]  

  • 11. Two randomised and placebo-controlled studies of an oral prostacyclin analogue (Iloprost) in severe leg ischaemia. The Oral Iloprost in severe Leg Ischaemia Study Group.
    Eur J Vasc Endovasc Surg; 2000 Oct; 20(4):358-62. PubMed ID: 11038148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcutaneous gases determination in diabetic critical limb ischemia.
    Melillo E; Ferrari M; Balbarini A; Pedrinelli R
    Diabetes Care; 2005 Aug; 28(8):2081-2. PubMed ID: 16043766
    [No Abstract]   [Full Text] [Related]  

  • 13. [Randomized placebo-controlled studies of iloprost in treatment of lower limb critical ischaemia].
    Kharazov AF
    Angiol Sosud Khir; 2010; 16(3):27-33. PubMed ID: 21280291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological effects of iloprost (ZK 36 374), a stable prostacyclin analogue, in man.
    Ylitalo P; Kaukinen S; Seppäla E; Nurmi AK; Pessi T; Krais T; Vapaatalo H
    Biomed Biochim Acta; 1984; 43(8-9):S399-402. PubMed ID: 6083786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Significance of prostaglandins in arterial thrombosis pathology: survey of an ongoing experience].
    Duvivier A; David JL
    Rev Med Liege; 1984 May; 39(9):354-61. PubMed ID: 6203155
    [No Abstract]   [Full Text] [Related]  

  • 16. Possibilities for clinical use of prostacyclin in vascular disease.
    Poredos P
    Pflugers Arch; 2000; 440(5 Suppl):R137-8. PubMed ID: 11005643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of iloprost and factors affecting outcome in patients with severe inoperable lower limb ischaemia. U.K. Severe Limb Ischaemia Study Group.
    Belcher G
    Agents Actions Suppl; 1992; 37():354-60. PubMed ID: 1378690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does prostacyclin analogue Iloprost change blood rheology? Results from a double blind trial with intravenous application in diabetics.
    Ernst E; Marshall M; Matrai A
    Vasa; 1988; 17(2):89-91. PubMed ID: 2457284
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of oxygen-centered free radical formation by the stable prostacyclin-mimetic iloprost (ZK 36 374) in acute myocardial ischemia.
    Thiemermann C; Steinhagen-Thiessen E; Schrör K
    J Cardiovasc Pharmacol; 1984; 6(2):365-6. PubMed ID: 6200730
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacological interventions on critical limb ischemia in diabetic patients.
    Parekh N; Nanjundappa A; Dieter RS
    J Cardiovasc Surg (Torino); 2012 Feb; 53(1):39-43. PubMed ID: 22231528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.